355 related articles for article (PubMed ID: 36054524)
1. Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies.
Montalbano M; Majmundar L; Sengupta U; Fung L; Kayed R
Brain Pathol; 2023 Jan; 33(1):e13112. PubMed ID: 36054524
[TBL] [Abstract][Full Text] [Related]
2. Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer's disease, progressive supranuclear palsy and dementia with Lewy bodies.
Puangmalai N; Bhatt N; Montalbano M; Sengupta U; Gaikwad S; Ventura F; McAllen S; Ellsworth A; Garcia S; Kayed R
Cell Death Dis; 2020 May; 11(5):314. PubMed ID: 32366836
[TBL] [Abstract][Full Text] [Related]
3. Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration.
Briel N; Pratsch K; Roeber S; Arzberger T; Herms J
Brain Pathol; 2021 Jul; 31(4):e12914. PubMed ID: 33089580
[TBL] [Abstract][Full Text] [Related]
4. Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies.
Wetering JV; Geut H; Bol JJ; Galis Y; Timmermans E; Twisk JWR; Hepp DH; Morella ML; Pihlstrom L; Lemstra AW; Rozemuller AJM; Jonkman LE; van de Berg WDJ
Acta Neuropathol Commun; 2024 May; 12(1):73. PubMed ID: 38715119
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
6. Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.
Ando K; Tomimura K; Sazdovitch V; Suain V; Yilmaz Z; Authelet M; Ndjim M; Vergara C; Belkouch M; Potier MC; Duyckaerts C; Brion JP
Neurobiol Dis; 2016 Oct; 94():32-43. PubMed ID: 27260836
[TBL] [Abstract][Full Text] [Related]
7. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
9. Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration.
Martínez-Maldonado A; Ontiveros-Torres MÁ; Harrington CR; Montiel-Sosa JF; Prandiz RG; Bocanegra-López P; Sorsby-Vargas AM; Bravo-Muñoz M; Florán-Garduño B; Villanueva-Fierro I; Perry G; Garcés-Ramírez L; de la Cruz F; Martínez-Robles S; Pacheco-Herrero M; Luna-Muñoz J
J Alzheimers Dis; 2021; 79(4):1517-1531. PubMed ID: 33459640
[TBL] [Abstract][Full Text] [Related]
10. Distinct involvement of the cranial and spinal nerves in progressive supranuclear palsy.
Tanaka H; Martinez-Valbuena I; Forrest SL; Couto B; Reyes NG; Morales-Rivero A; Lee S; Li J; Karakani AM; Tang-Wai DF; Tator C; Khadadadi M; Sadia N; Tartaglia MC; Lang AE; Kovacs GG
Brain; 2024 Apr; 147(4):1399-1411. PubMed ID: 37972275
[TBL] [Abstract][Full Text] [Related]
11. Human tau pathology transmits glial tau aggregates in the absence of neuronal tau.
Narasimhan S; Changolkar L; Riddle DM; Kats A; Stieber A; Weitzman SA; Zhang B; Li Z; Roberson ED; Trojanowski JQ; Lee VMY
J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31826239
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
Chalmers KA; Love S
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
[TBL] [Abstract][Full Text] [Related]
13. Calpain activation in neurodegenerative diseases: confocal immunofluorescence study with antibodies specifically recognizing the active form of calpain 2.
Adamec E; Mohan P; Vonsattel JP; Nixon RA
Acta Neuropathol; 2002 Jul; 104(1):92-104. PubMed ID: 12070670
[TBL] [Abstract][Full Text] [Related]
14. Identification of G-protein coupled receptor kinase 2 in paired helical filaments and neurofibrillary tangles.
Takahashi M; Uchikado H; Caprotti D; Weidenheim KM; Dickson DW; Ksiezak-Reding H; Pasinetti GM
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1157-69. PubMed ID: 17146290
[TBL] [Abstract][Full Text] [Related]
15. [Pathologic diagnosis of non-Alzheimer type dementia].
Zhu MW; Wang LN; Li XH; Hu YZ
Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):408-12. PubMed ID: 15498207
[TBL] [Abstract][Full Text] [Related]
16. Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy.
Piras A; Collin L; Grüninger F; Graff C; Rönnbäck A
Acta Neuropathol Commun; 2016 Mar; 4():22. PubMed ID: 26936765
[TBL] [Abstract][Full Text] [Related]
17. Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease.
Botez G; Probst A; Ipsen S; Tolnay M
Acta Neuropathol; 1999 Sep; 98(3):251-6. PubMed ID: 10483782
[TBL] [Abstract][Full Text] [Related]
18. Tau seeds from patients induce progressive supranuclear palsy pathology and symptoms in primates.
Darricau M; Katsinelos T; Raschella F; Milekovic T; Crochemore L; Li Q; Courtine G; McEwan WA; Dehay B; Bezard E; Planche V
Brain; 2023 Jun; 146(6):2524-2534. PubMed ID: 36382344
[TBL] [Abstract][Full Text] [Related]
19. Selective tau tyrosine nitration in non-AD tauopathies.
Reyes JF; Geula C; Vana L; Binder LI
Acta Neuropathol; 2012 Jan; 123(1):119-32. PubMed ID: 22057784
[TBL] [Abstract][Full Text] [Related]
20. Cellular and pathological heterogeneity of primary tauopathies.
Chung DC; Roemer S; Petrucelli L; Dickson DW
Mol Neurodegener; 2021 Aug; 16(1):57. PubMed ID: 34425874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]